Evidence map›Paper›PMID 37863864›Full record

ArticleJournal of patient-reported outcomes2023

Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).

Helena Bradley, Claire Trennery, Amy M Jones, Aoife Lydon, Frances White, Rebecca Williams-Hall, Rob Arbuckle, Erin Tomaszewski, Vivian H Shih, John Haughney and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of patient-reported outcomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Helena BradleyAdelphi Values Ltd, Bollington, Cheshire, UK. helena.bradley@adelphivalues.com.ORCID 0000-0002-7077-2183
Claire TrenneryGlaxoSmithKline, London, UK.
Amy M JonesAdelphi Values Ltd, Bollington, Cheshire, UK.
Aoife LydonAdelphi Values Ltd, Bollington, Cheshire, UK.
Frances WhiteAdelphi Values Ltd, Bollington, Cheshire, UK.
Rebecca Williams-HallAdelphi Values Ltd, Bollington, Cheshire, UK.
Rob ArbuckleAdelphi Values Ltd, Bollington, Cheshire, UK.
Erin TomaszewskiAstraZeneca, Gaithersburg, MD, USA.
Vivian H ShihAstraZeneca, Gaithersburg, MD, USA.
John HaughneyNHS Greater Glasgow and Clyde R&I, Queen Elizabeth University Hospital, Glasgow, UK.
Amanda EisenAllergy and Asthma Network, Vienna, VA, USA.
Tonya WindersGlobal Allergy and Airways Patient Platform, Vienna, Austria.
Stephen Joel CoonsPatient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA.
Sonya EremencoPatient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA.
Patient-Reported Outcome Consortium’s Pediatric Asthma Working Group
Adelphi Group (United Kingdom) · GBAstraZeneca (United States) · USCritical Path Institute · USGlaxoSmithKline (United Kingdom) · GBNHS Greater Glasgow and Clyde · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric asthma has been identified by regulators, clinicians, clinical trial sponsors, and caregivers as an area in need of novel fit-for-purpose clinical outcome assessments (COAs) developed in accordance with the U.S. Food and Drug Administration's (FDA's) regulatory guidance for evaluating clinical benefit in treatment trials. To address this gap, the Patient-Reported Outcome (PRO) Consortium's Pediatric Asthma Working Group has continued development of 2 COAs to assess asthma signs and symptoms in pediatric asthma clinical trials to support efficacy endpoints: a PRO measure, the Pediatric Asthma Diary-Child (PAD-C) for children 8-11 years old (y.o.) and an observer-reported outcome measure, the Pediatric Asthma Diary-Observer (PAD-O) for caregivers of children 4-11 y.o. This qualitative research aimed to generate evidence regarding the content validity of the PAD-C and PAD-O.

methodsSemi-structured combined concept elicitation and cognitive interviews were conducted with a diverse sample of U.S. participants (15 children 8-11 y.o. and 30 caregivers of children 4-11 y.o.). All children had clinician-diagnosed mild to severe asthma. Interviews explored the experience of pediatric asthma and assessed the understanding and relevance of both measures. Interviews were conducted across 3 iterative rounds to allow for modifications.

resultsConcept elicitation findings demonstrated that the core sign/symptom and impact concepts assessed in the PAD-C (cough, hard to breathe, out of breath, wheezing, chest tightness, and nighttime awakenings/symptoms) and PAD-O (cough, difficulty breathing, short of breath, wheezing, and nighttime awakenings/signs) correspond to those most frequently reported by participants; concept saturation was achieved. All PAD-C and PAD-O instructions and core items were well understood and considered relevant by most participants. Feedback from participants, the Pediatric Asthma Working Group, advisory panel, and FDA supported modifications to the measures, including addition of 1 new item to both measures and removal of 1 caregiver item.

conclusionsFindings provide strong support for the content validity of both measures. The cross-sectional measurement properties of both measures and their user experience and feasibility in electronic format will be assessed in a future quantitative pilot study with qualitative exit interviews, intended to support the reliability, construct validity, final content, and, ultimately, FDA qualification of the measures.

Indexed as

AsthmaCoughChildCross-Sectional StudiesHumansPilot ProjectsQualitative ResearchReproducibility of ResultsRespiratory SoundsDevelopmentDiaryInterviewMeasurementObserver-reported outcome (ObsRO)Patient-reported outcome (PRO)Pediatric asthmaQualitativeSignsSymptoms

Identifiers

PMID37863864
PMCPMC10589163
OpenAlexW4387806942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.